Closed to new claimsData privacyGoodRx Privacy Settlement: What You Can Actually Claim
Last updated: July 25, 2026
As of 2026, there is no GoodRx settlement money that consumers can claim, and there is no claim form to file. GoodRx did agree to pay $1.5 million in 2023 — but that was a civil penalty to the Federal Trade Commission (FTC) that, by law, went to the U.S. Treasury, not to individual users. A separate private class action that could have paid consumers has been rejected by the court twice, most recently on January 16, 2026, so no fund, deadline, or payout exists. Any website telling you to "claim your GoodRx settlement" for a dollar amount is not describing a real, payable settlement.
GoodRx Holdings, Inc. runs a popular prescription-discount and telehealth service used by tens of millions of Americans. In February 2023, the FTC — in United States v. GoodRx Holdings (No. 3:23-cv-00460, N.D. California) — brought the first-ever enforcement action under its Health Breach Notification Rule, alleging that from roughly 2017 to 2020 GoodRx shared users' sensitive health information (the medications and conditions they searched) with advertising and analytics companies including Facebook (Meta), Google, and Criteo, without consent and without notifying users. GoodRx agreed to a $1.5 million penalty and to stop the practice; that penalty is not distributed to consumers.
There is also a private lawsuit, Doe v. GoodRx Holdings (No. 3:23-cv-00501, N.D. California), that seeks money for users over the same data-sharing. A proposed $25 million settlement was rejected in 2025, and a revised $32 million version was denied preliminary approval on January 16, 2026, because the court could not confirm it was fair to the class. Because no settlement has been approved, no claim website, deadline, or payment exists today. The case could be revised or continue in litigation, but for now there is nothing to claim.
Key facts
- Consumer payout
- None available to claim now
- FTC penalty
- $1.5M to U.S. Treasury (Feb 2023)
- FTC case
- U.S. v. GoodRx Holdings, 3:23-cv-00460 (N.D. Cal.)
- Alleged conduct
- Shared health data with Meta, Google, Criteo (~2017–2020)
- Private class action
- Doe v. GoodRx, 3:23-cv-00501 (N.D. Cal.)
- Class-action status
- Preliminary approval denied Jan 16, 2026
- Claim form / deadline
- None exists
- "GoodRx payout" claim sites
- Not official — no payout to claim
Official settlement administrator: FTC — U.S. v. GoodRx enforcement action
Who qualifies
- The FTC penalty does not create any consumer eligibility — a civil penalty is paid to the U.S. Treasury, so there is no per-person GoodRx check, refund, or claim tied to it.
- The private class action (Doe v. GoodRx) proposed to cover U.S. individuals who used GoodRx's website, app, or services during the relevant period — but no settlement has been approved, so no one can file a claim yet.
- GoodRx's only consumer-facing obligation under the FTC order was to notify affected users and stop sharing their health data. It was not required to pay individuals.
- If a website asks you to submit personal information to "claim" a GoodRx settlement amount today, it is not an official settlement — there is no approved fund and no claim process.
GoodRx settlement status — what to know now
- 1
There is no GoodRx claim to file right now
No approved settlement means no claim form, no deadline, and no per-person payout. The FTC action is closed and its penalty went to the government; the private class action has not been approved. Anyone offering a GoodRx claim form with a dollar figure is not describing a real settlement.
- 2
The FTC's $1.5 million went to the Treasury, not to you
In February 2023 the FTC settled United States v. GoodRx Holdings for a $1.5 million civil penalty — its first case under the Health Breach Notification Rule. Civil penalties are paid to the U.S. Treasury by law, so this money is not distributed to GoodRx users as refunds or checks.
- 3
The private class action has been rejected twice
Doe v. GoodRx Holdings sought money for users over the same data-sharing. A $25 million proposal was rejected in 2025, and a revised $32 million version was denied preliminary approval on January 16, 2026. The judge could not confirm the deal was fair to the class, so no fund or claim process was ever opened.
- 4
Watch for fake "GoodRx settlement" claim sites
Because "GoodRx settlement" is a high-traffic search, scam and content-farm sites publish fake claim pages with invented payout amounts and deadlines. There is no official GoodRx payout to claim — never enter your Social Security number, bank details, or health information to "claim" one.
- 5
We'll tell you if a real GoodRx payout ever opens
If the class action is revised and a court finally approves a payable settlement, a real claim process would launch. ClaimBee tracks cases like this, matches settlements to your profile, and flags fake "settlements" so you only spend time on legitimate claims.
Missed this one? Don't miss the next.
ClaimBee matches your profile against 2,000+ active settlements, shows payout and proof requirements up front, and tracks every deadline for you.
Frequently asked questions
Is the GoodRx settlement real?
Partly. GoodRx really did settle with the FTC in 2023 for a $1.5 million penalty over sharing users' health data. But that penalty went to the U.S. Treasury, not to consumers, and a separate class action that could pay users has been rejected twice. So the enforcement action is real, but there is no consumer payout to claim.
Can I get money or a refund from GoodRx?
Not right now. There is no approved settlement that pays GoodRx users, no claim form, and no deadline. The FTC's $1.5 million penalty is government money, and the private class action (Doe v. GoodRx) was denied approval as recently as January 16, 2026. Nothing is currently payable to individuals.
How do I file a GoodRx settlement claim?
You cannot — there is no official GoodRx claim process. No settlement administrator, claim website, or deadline exists because no consumer settlement has been approved. Any site inviting you to file a GoodRx claim and enter personal data is not legitimate.
What did GoodRx do wrong?
The FTC alleged that from about 2017 to 2020, GoodRx shared users' sensitive health information — the prescriptions and conditions they looked up — with advertising and analytics companies including Facebook (Meta), Google, and Criteo, without users' consent and without notifying them as the Health Breach Notification Rule requires. GoodRx agreed to stop and paid a $1.5 million penalty.
Where did the $1.5 million GoodRx penalty go?
To the U.S. Treasury. It was a civil penalty for violating the FTC's Health Breach Notification Rule, and civil penalties are paid to the government, not distributed to consumers. That is why there is no GoodRx refund or per-person check from the FTC case.
Could there ever be a GoodRx payout to consumers?
Possibly. The private class action, Doe v. GoodRx Holdings, is still active after its proposed settlements were rejected. If the parties craft a new deal and a court approves it, a real claim process with a fund and deadline could open. Until that happens, there is nothing to claim.
Sources and official records
Every figure and date on this page was taken from the primary records below — court dockets, agency releases, and the settlement administrator's own notices. Payout averages we describe as averages are calculated from the official totals, not reported per-person estimates.
Related settlements
Closed · Data privacy
Cerebral Data Privacy Settlement & FTC Refund
~$125 avg FTC (sent) · CA paid · Closed — refunds paid 2025–26
Closed · Data privacy
BetterHelp $7.8 Million FTC Privacy Settlement
~$10/person (paid out) · No claim needed
Closed · Data breach
Blackbaud Data Breach Settlement
None — no consumer claim · No consumer claim
Closed · Data privacy
PowerSchool Naviance $17.25 Million Privacy Settlement
Equal pro rata share — amount not yet set · Claims closed July 27, 2026
More settlements people are checking
Payout status for other settlements we track, updated as administrators publish new information.